American Century Companies’s NxStage Medical Inc. NXTM Stock Holding History

American Century Companies’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-30,173	Closed	-$791K	–	1423
2016 Q4	$791K	Sell	30,173 -34,754	-54%	-$860K	﹤0.01%	1169
2016 Q3	$1.62M	Buy	64,927 +3,643	+6%	+$84.9K	﹤0.01%	1089
2016 Q2	$1.33M	Buy	+61,284	New	+$1.09M	﹤0.01%	1096
2013 Q4	–	Sell	-58,553	Closed	-$771K	–	1541
2013 Q3	$771K	Buy	58,553 +3,810	+7%	+$50K	﹤0.01%	1287
2013 Q2	$782K	Buy	+54,743	New	+$688K	﹤0.01%	1254

Other funds holding NXTM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

PCM

Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

American Century Companies's NXTM Position: Q1 2017 in Review

American Century Companies sold out of NxStage Medical Inc. (NXTM) in Q1 2017, closing a stake of 30,173 shares — an estimated $791K sold.

American Century Companies first reported a position in NXTM in Q2 2013 and held it in 5 quarters. The position peaked at $1.62M in Q3 2016. 171 funds tracked by Wall St. Rank hold NXTM as of Q1 2017.

American Century Companies reported no remaining NxStage Medical Inc. position as of Q1 2017 after selling out during the quarter.
American Century Companies sold 30,173 NxStage Medical Inc. shares in Q1 2017, an estimated $791K.
American Century Companies first reported a position in NxStage Medical Inc. in Q2 2013 and held it in 5 quarters.
American Century Companies's NxStage Medical Inc. position peaked at $1.62M in Q3 2016.
171 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2017.

Based on American Century Companies's 13F filing for Q1 2017, filed 2 May 2017.